Acidic sphingomyelinase induced by electrophiles promotes proinflammatory cytokine production in human bladder carcinoma ECV-304 cells.
Electrophiles in environmental pollutants or cigarette smoke are high risk factors for various diseases caused by cell injuries such as apoptosis and inflammation. Here we show that electrophilic compounds such as diethyl malate (DEM), methyl mercury and cigarette smoke extracts significantly enhanced the expression of acidic sphingomyelinase (ASMase). ASMase activity and the amount of ceramide of DEM-treated cells were approximately 6 times and 4 times higher than these of non-treated cells, respectively. Moreover, we found that DEM pretreatment enhanced the production of IL-6 induced by TNF-α. Knockdown of ASMase attenuated the enhancement of TNF-α-dependent IL-6 production. On the other hand, enhancement of TNF-α-induced IL-6 production was observed in ASMase-overexpressing cells without DEM. Fractionation of the lipid raft revealed that the TNF receptor 1 (TNFR1) was migrated into the lipid raft in DEM-treated cells or ASMase-overexpressing cells. The TNF-α-induced IL-6 expression required the clustering of TNFR1 since IL-6 expression were decreased by the destruction of the lipid raft with filipin. These results demonstrated a new role for ASMase in the acceleration of the production of TNF-induced IL-6 as a pro-inflammatory cytokine and indicated that electrophiles could potentiate inflammation response by up-regulating of ASMase expression following formation of lipid rafts.
Laboratory of Hygienic Chemistry, School of Pharmaceutical Sciences, Kitasato University, 5-9-1 Shirokane, Minato-ku, Tokyo 108-8641, Japan. kumagait@pharm.kitasato-u.ac.jp
Takeshi
T
Kumagai
Tomohiro
T
Ishino
Yasuhito
Y
Nakagawa
D017209:Apoptosis / Q000187:drug effects; D002277:Carcinoma / Q000276:immunology / Q000378:metabolism* / Q000473:pathology; D045744:Cell Line, Tumor; D002518:Ceramides / Q000737:chemistry / Q000378:metabolism; D045424:Complex Mixtures; D004785:Environmental Pollutants / Q000633:toxicity*; D006801:Humans; D007249:Inflammation / Q000276:immunology / Q000378:metabolism / Q000473:pathology; D015850:Interleukin-6 / Q000819:agonists* / Q000276:immunology; D008293:Malates / Q000633:toxicity*; D021962:Membrane Microdomains / Q000737:chemistry / Q000378:metabolism; D008767:Methylmercury Compounds / Q000633:toxicity*; D021381:Protein Transport; D047888:Receptors, Tumor Necrosis Factor, Type I / Q000378:metabolism; D015398:Signal Transduction; D013108:Sphingomyelin Phosphodiesterase / Q000235:genetics / Q000378:metabolism*; D014026:Nicotiana / Q000633:toxicity*; D014409:Tumor Necrosis Factor-alpha / Q000819:agonists / Q000276:immunology; D015854:Up-Regulation; D001749:Urinary Bladder Neoplasms / Q000276:immunology / Q000378:metabolism* / Q000473:pathology
D002518:Ceramides; D045424:Complex Mixtures; D004785:Environmental Pollutants; D015850:Interleukin-6; D008293:Malates; D008767:Methylmercury Compounds; D047888:Receptors, Tumor Necrosis Factor, Type I; D014409:Tumor Necrosis Factor-alpha; C058705:diethyl malate; D013108:Sphingomyelin Phosphodiesterase